List of Arbutus Biopharma Corporation patents

Patents where

Current Assignee

Name

Arbutus Biopharma Corporation

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11786598 Lipid formulations for delivery of therapeutic agents	Patent 11786598 was granted and assigned to Arbutus Biopharma Corporation on October, 2023 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11786598	October 17, 2023
‌ US Patent 11446383 Lipid formulations for delivery of therapeutic agents	Patent 11446383 was granted and assigned to Arbutus Biopharma Corporation on September, 2022 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11446383	September 20, 2022
‌ US Patent 10077232 Cyclic cationic lipids and methods of use	Patent 10077232 was granted and assigned to Arbutus Biopharma Corporation on September, 2018 by the United States Patent and Trademark Office.		Arbutus Biopharma Corporation	United States Patent and Trademark Office	10077232	September 18, 2018
‌ US Patent 11427823 Targeted compositions	Patent 11427823 was granted and assigned to Arbutus Biopharma Corporation on August, 2022 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11427823	August 30, 2022
‌ US Patent 10561732 Trialkyl cationic lipids and methods of use thereof	Patent 10561732 was granted and assigned to Arbutus Biopharma Corporation on February, 2020 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	10561732	February 18, 2020
‌ US Patent 9394234 Lipid formulations	Patent 9394234 was granted and assigned to Arbutus Biopharma Corporation on July, 2016 by the United States Patent and Trademark Office.	‌ Tekmira Pharmaceuticals Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	9394234	July 19, 2016
‌ US Patent 11191849 Compositions and methods for delivering messenger RNA	Patent 11191849 was granted and assigned to Arbutus Biopharma Corporation on December, 2021 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11191849	December 7, 2021
‌ US Patent 11395854 Trialkyl cationic lipids and methods of use thereof	Patent 11395854 was granted and assigned to Arbutus Biopharma Corporation on July, 2022 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11395854	July 26, 2022
‌ US Patent 10415037 Compositions and methods for silencing hepatitis B virus gene expression	Patent 10415037 was granted and assigned to Arbutus Biopharma Corporation on September, 2019 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	10415037	September 17, 2019
‌ US Patent 9682139 Lipids and compositions for the delivery of therapeutics	Patent 9682139 was granted and assigned to Arbutus Biopharma Corporation on June, 2017 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	9682139	June 20, 2017
‌ US Patent 9707292 Lipids and compositions for the delivery of therapeutics	Patent 9707292 was granted and assigned to Arbutus Biopharma Corporation on July, 2017 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	9707292	July 18, 2017
‌ US Patent 9764036 Lipids and compositions for the delivery of therapeutics	Patent 9764036 was granted and assigned to Arbutus Biopharma Corporation on September, 2017 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	9764036	September 19, 2017
‌ US Patent 11351118 Methods for ameliorating infusion reactions	Patent 11351118 was granted and assigned to Arbutus Biopharma Corporation on June, 2022 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11351118	June 7, 2022
‌ US Patent 11318098 Liposomal apparatus and manufacturing methods		Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11318098	May 3, 2022
‌ US Patent 11298320 Liposomal apparatus and manufacturing methods	Patent 11298320 was granted and assigned to Arbutus Biopharma Corporation on April, 2022 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11298320	April 12, 2022
‌ US Patent 11420931 Lipid containing formulations		Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11420931	August 23, 2022
‌ US Patent 10117941 Lipids and compositions for the delivery of therapeutics	Patent 10117941 was granted and assigned to Arbutus Biopharma Corporation on November, 2018 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	10117941	November 6, 2018
‌ US Patent 11077197 Lipids and compositions for the delivery of therapeutics	Patent 11077197 was granted and assigned to Arbutus Biopharma Corporation on August, 2021 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11077197	August 3, 2021
‌ US Patent 9694077 Lipid compositions	Patent 9694077 was granted and assigned to Arbutus Biopharma Corporation on July, 2017 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	9694077	July 4, 2017
‌ US Patent 10456473 Lipid compositions	Patent 10456473 was granted and assigned to Arbutus Biopharma Corporation on October, 2019 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	10456473	October 29, 2019
‌ US Patent 10953095 Lipid compositions	Patent 10953095 was granted and assigned to Arbutus Biopharma Corporation on March, 2021 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	10953095	March 23, 2021
‌ US Patent 10053689 Methods for increasing efficacy of lipid formulated siRNA	Patent 10053689 was granted and assigned to Arbutus Biopharma Corporation on August, 2018 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	10053689	August 21, 2018
‌ US Patent 9687550 Compositions for nucleic acid delivery	Patent 9687550 was granted and assigned to Arbutus Biopharma Corporation on June, 2017 by the United States Patent and Trademark Office.		Arbutus Biopharma Corporation	United States Patent and Trademark Office	9687550	June 27, 2017
‌ US Patent 9636301 In vitro release assay for liposome encapsulated vincristine	Patent 9636301 was granted and assigned to Arbutus Biopharma Corporation on May, 2017 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	9636301	May 2, 2017
‌ US Patent 11505551 Methods for preparing substituted pyridinone-containing tricyclic compounds	Patent 11505551 was granted and assigned to Arbutus Biopharma Corporation on November, 2022 by the United States Patent and Trademark Office.	Arbutus Biopharma Corporation	Arbutus Biopharma Corporation	United States Patent and Trademark Office	11505551	November 22, 2022

Results per page:

46 results

0 selected

46 results

0 selected